摘要
A series of 7-arylindoline-1-benzenesulfonamides were prepared and evaluated for anticancer activity. 7-(4′-Cyanophenyl)indoline-1- benzenesulfonamide 15 exhibited substantial antiproliferative activity with IC50 values ranging from 17-32 nM against a variety of human cancer cell lines, including MDR resistant line. Compound 15 (IC50 = 1.5 μM) also showed more potent inhibition of tubulin polymerization than 4a (combretastatin A-4, IC50 = 2.0 μM) and displayed strong binding to the colchicine binding site of the tubulin.
原文 | 英語 |
---|---|
頁(從 - 到) | 152-155 |
頁數 | 4 |
期刊 | MedChemComm |
卷 | 1 |
發行號 | 2 |
DOIs | |
出版狀態 | 已發佈 - 8月 2010 |
ASJC Scopus subject areas
- 藥物發現
- 分子醫學
- 生物化學
- 藥理
- 藥學科學
- 有機化學